Select Medical Holdings Reports Strong Q3 Results
Select Medical Holdings Corporation (NYSE: SEM) has recently shared its impressive financial results for the third quarter. The company demonstrated robust growth while also announcing a cash dividend for its shareholders. This release provides a detailed overview of its performance metrics.
Financial Highlights of Q3
For the third quarter, Select Medical experienced a revenue increase of 5.7%, reaching approximately $1,761.2 million compared to $1,665.7 million from the same quarter of the previous year. The increase in revenue reflects a successful operational strategy and alignment with market demand.
The income from operations rose by 8.6%, marking a significant leap to $141.1 million from $130.0 million in the prior year. Likewise, net income saw an impressive growth of 33.2%, totaling $81.0 million compared to $60.8 million last year. This growth trajectory highlights the company's effective management and operational efficiencies.
Adjusted EBITDA and Earnings Per Share
Adjusted EBITDA for the quarter was up by 6.0%, achieving $205.5 million, while earnings per share increased by 13.2%, reaching $0.43. The adjusted earnings per share also saw a healthy rise of 8.7%, coming in at $0.50.
Year-to-Date Performance
Looking at the year-to-date figures, revenue reflected a steady increase of 6.1%, amounting to $5,309.7 million, while income from operations surged by 11.9% to $492.9 million. Net income grew by 23.1%, reaching $292.9 million for the nine months ended. This performance demonstrates a consistent growth pattern and strong financial health.
Segments Analysis: Critical and Rehabilitation Hospitals
The critical illness recovery hospital segment saw revenue climbing 3.4% to $583.0 million in Q3, up from $563.6 million in the previous year. Adjusted EBITDA for this segment also showed improvement, increasing 9.5% to $50.8 million compared to $46.4 million last year.
In the rehabilitation hospital segment, revenue surged by 14.4% to $282.7 million. Alongside this, adjusted EBITDA increased by 12.1%, hitting $60.1 million, illustrating the growth trajectory of this segment.
Dividend Declaration and Future Outlook
The Board of Directors has also declared a cash dividend of $0.125 per share, which will be payable shortly to shareholders of record. This decision not only reflects the company’s confidence in its ongoing profitability but also aligns with its commitment to providing value to shareholders.
As Select Medical moves forward, its expectations for full-year revenue are projected between $6.95 billion and $7.15 billion, showing a strong outlook for continued growth.
Conclusion
Select Medical Holdings remains a prominent player in the healthcare industry, offering critical illness recovery services and outpatient rehabilitation. With substantial Q3 results and an optimistic outlook for the future, stakeholders can anticipate sustained growth and dividends. The company continues to focus on strategic advancements and operational improvements, reinforcing its standing in the market.
Frequently Asked Questions
What were Select Medical's total revenues for Q3?
Select Medical's total revenues for Q3 reached $1,761.2 million, a 5.7% increase from the previous year.
How much did the net income increase in Q3?
The net income during Q3 increased by 33.2%, totaling $81.0 million.
What dividend amount has the Select Medical Board declared?
The Board declared a cash dividend of $0.125 per share, payable soon to stockholders of record.
What is the projected revenue range for the full year 2024?
Select Medical anticipates full-year 2024 revenues to be between $6.95 billion and $7.15 billion.
Which segments of Select Medical showed the highest growth in Q3?
The rehabilitation hospital segment saw the highest growth, with a revenue increase of 14.4% in Q3.
